Webinars & Presentations Webinars & Presentations Sort ByMost RecentOldestApplicationsVirus-like ParticlesCell Based AssaysCell TherapyCRISPR/Gene EditingGene EditingProtein ProductionCell TypesCancer Cell LinesCHODendritic CellsHEK293HSPCsInsect Cell Lines (S2/Sf9/Sf21)ion channelsiPSCsNK CellsNPCs/NSCsPBMCsT CellsSubmit Protein Production HEK293 Therapeutic Antibody Discovery by Mammalian Display iONTAS’s innovative antibody discovery technology can save time and effort downstream by addressing antibody developability issues during the initial phase of biotherapeutic discovery. Protein Production CHO Winning the Race: Decreasing Protein Development Timelines with Scalable Cell Engineering The critical role of a flexible, reproducible and scalable technology for cellular engineering in the rapid development of protein therapeutics. Cell Based Assays CRISPR/Gene Editing iPSCs NPCs/NSCs High Transfection Efficiency of Human Induced Pluripotent Stem Cells and Their Derivatives High transfection efficiencies of plasmids expressing CRISPR/Cas9 in hiPSCs and iPSC-derived cell lines improved genomic DNA editing efficiency in hiPSCs by up to 10-fold. Cell Therapy NK Cells Improving NK Cell-based Cancer Immunotherapy via mRNA Electroporation Natural Killer (NK) cells are cytotoxic lymphocytes that can kill tumor-transformed and infected cells. – December 2017 Protein Production CHO Targeted Locus Amplification for Transgene Sequencing in rCHO Clones Expressing Therapeutic Lysosomal Enzyme Targeted locus amplification (TLA) to identify genomic sites of transgene integration and transgene sequence integrity to assess the suitability of recombinant CHO clones for the generating of candidate therapeutic proteins pre-clinical studies. Cell Based Assays CRISPR/Gene Editing Insect Cell Lines (S2/Sf9/Sf21) Decoding Transcriptional Regulation by Genome-Wide Reporter Assays and Large-Scale Transfection STARR-seq and STAP-seq reporter assays for the measurement of the activity of candidate enhancer and promoter sequences enabled by MaxCyte’s scalable flow electroporation technology. Protein Production CHO Solving Problems in the Production of Complex Proteins and Other Biologics Express quality, bioactive bispecific antibodies, BITEs, tribodies, and full IgGs in CHO cells using a consistent, scalable electroporation technology. Cell Therapy CRISPR/Gene Editing HSPCs CRISPR-mediated Mutation Correction of Hematopoietic Stem Cells from Patients with X-linked Chronic Granulomatous Disease Using Non-Viral Cell Engineering CRISPR (clustered regularly interspaced short palindromic repeats)-mediated gene modification presents a powerful avenue for the treatment of patients with genetic diseases. – March 2017 Protein Production CHO HEK293 Insect Cell Lines (S2/Sf9/Sf21) Rapid Cell Line Development and Efficient Genome Modification using Scalable Electroporation Rapid generation of stable pools and identification of high-yielding clones enabled by high transfection efficiency and cell viability following MaxCyte electroporation Protein Production CHO Synergizing Transient and Stable Protein Expression for Accelerated Biotherapeutic Development Parallel track large-scale transient expression and rapid stable clone generation in biomanufacturing relevant cells by integrating MaxCyte’s electroporation technology into biotherapeutic development programs. Pages: 12345Load More Webinars<div class='no-results'>There are no results found here</div> Publication View Publications Featured Science View Featured Science
